180 related articles for article (PubMed ID: 32903274)
1. Toll-like receptor 4-mediated inflammation triggered by extracellular IFI16 is enhanced by lipopolysaccharide binding.
Iannucci A; Caneparo V; Raviola S; Debernardi I; Colangelo D; Miggiano R; Griffante G; Landolfo S; Gariglio M; De Andrea M
PLoS Pathog; 2020 Sep; 16(9):e1008811. PubMed ID: 32903274
[TBL] [Abstract][Full Text] [Related]
2. The Extracellular IFI16 Protein Propagates Inflammation in Endothelial Cells Via p38 MAPK and NF-κB p65 Activation.
Bawadekar M; De Andrea M; Lo Cigno I; Baldanzi G; Caneparo V; Graziani A; Landolfo S; Gariglio M
J Interferon Cytokine Res; 2015 Jun; 35(6):441-53. PubMed ID: 25715050
[TBL] [Abstract][Full Text] [Related]
3. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
4. Anti-Inflammatory Activity of Adenosine 5'-Trisphosphate in Lipopolysaccharide-Stimulated Human Umbilical Vein Endothelial Cells Through Negative Regulation of Toll-Like Receptor MyD88 Signaling.
Luo X; Xiao B; Xiao Z
DNA Cell Biol; 2019 Dec; 38(12):1557-1563. PubMed ID: 31580158
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways.
Dejkhamron P; Thimmarayappa J; Kotlyarevska K; Sun J; Lu C; Bonkowski EL; Denson LA; Menon RK
Mol Cell Endocrinol; 2007 Aug; 274(1-2):35-42. PubMed ID: 17601656
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor translocation and acute anterior uveitis.
Wang J; Lu H; Hu X; Chen W; Xu Z; Li S; Xu Y
Mol Vis; 2011 Jan; 17():170-6. PubMed ID: 21264236
[TBL] [Abstract][Full Text] [Related]
7. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
[TBL] [Abstract][Full Text] [Related]
8. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages.
Lee IA; Hyam SR; Jang SE; Han MJ; Kim DH
J Agric Food Chem; 2012 Sep; 60(38):9595-602. PubMed ID: 22849695
[TBL] [Abstract][Full Text] [Related]
10. Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts.
Chen J; Ullah H; Zheng Z; Gu X; Su C; Xiao L; Wu X; Xiong F; Li Q; Zha L
BMC Complement Med Ther; 2020 Jun; 20(1):167. PubMed ID: 32493316
[TBL] [Abstract][Full Text] [Related]
11. Rifampicin ameliorates lipopolysaccharide-induced cognitive and motor impairments via inhibition of the TLR4/MyD88/NF-κB signaling pathway in mice.
Bi W; Cheng X; Zeng Z; Zhou R; Luo R; Zhang J; Zhu L
Neurol Res; 2021 May; 43(5):358-371. PubMed ID: 33749522
[TBL] [Abstract][Full Text] [Related]
12. Lys694Arg polymorphism leads to blunted responses to LPS by interfering TLR4 with recruitment of MyD88.
Yang Y; Hu Y; Zhou Y; Liang T; Tang H; Ju H; Shi Q; Fang H
Innate Immun; 2021 Aug; 27(6):483-492. PubMed ID: 32513051
[TBL] [Abstract][Full Text] [Related]
13. Bupivacaine inhibits the TLR4- and TLR2-Myd88/NF-κB pathways in human leukocytes.
Binczak M; Purenne E; Beloeil H; Benhamou D; Mazoit JX
Fundam Clin Pharmacol; 2023 Apr; 37(2):347-358. PubMed ID: 36191347
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
[TBL] [Abstract][Full Text] [Related]
15. Activation of Toll-like receptors by Burkholderia pseudomallei.
West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2.
Kim SY; Koo JE; Seo YJ; Tyagi N; Jeong E; Choi J; Lim KM; Park ZY; Lee JY
Br J Pharmacol; 2013 Apr; 168(8):1933-45. PubMed ID: 23231684
[TBL] [Abstract][Full Text] [Related]
17. Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway.
Hu N; Wang C; Dai X; Zhou M; Gong L; Yu L; Peng C; Li Y
J Ethnopharmacol; 2020 Feb; 248():112361. PubMed ID: 31683033
[TBL] [Abstract][Full Text] [Related]
18. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
[TBL] [Abstract][Full Text] [Related]
19. Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4.
Pizzuto M; Lonez C; Baroja-Mazo A; Martínez-Banaclocha H; Tourlomousis P; Gangloff M; Pelegrin P; Ruysschaert JM; Gay NJ; Bryant CE
Cell Mol Life Sci; 2019 Sep; 76(18):3667-3678. PubMed ID: 31062071
[TBL] [Abstract][Full Text] [Related]
20. Soyasaponin Bb inhibits the recruitment of toll-like receptor 4 (TLR4) into lipid rafts and its signaling pathway by suppressing the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent generation of reactive oxygen species.
Zhang Y; Chen F; Chen J; Huang S; Chen J; Huang J; Li N; Sun S; Chu X; Zha L
Mol Nutr Food Res; 2016 Jul; 60(7):1532-43. PubMed ID: 27005845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
